Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-1910-5p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 428, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
TMEM165 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr4:55424618-55424644 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ARHGAP32 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr11:129024105-129024130 HITS-CLIP POSITIVE DIRECT TarBase 7.0
WDR36 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.840
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr5:111124159-111124177 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CTSL hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:87726211-87726231 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SYNCRIP hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:85614873-85614899 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PRRG4 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr11:32840124-32840149 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GDF11 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:55749624-55749645 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HNRNPA1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.892
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:54285485-54285510 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CD164 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:109368823-109368850 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCT7 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr2:73239659-73239676 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KAT7 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr17:49788716-49788742 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DPM2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.586
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:127935241-127935268 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TJAP1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.650
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:43506344-43506365 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ACTR2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.452
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:65268824-65268849 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC5A6 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.570
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr2:27200047-27200064 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CENPO hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:24819681-24819706 HITS-CLIP POSITIVE DIRECT TarBase 7.0
G3BP2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.711
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr4:75645203-75645220 HITS-CLIP POSITIVE DIRECT TarBase 7.0
C1RL hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.648
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr12:7096318-7096341 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LRIG3 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:58920057-58920079 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MARCH9 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.752
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:57755150-57755171 HITS-CLIP POSITIVE DIRECT TarBase 7.0